Management of acute ischemic stroke

PREVIEW

In the last 5 years, management of acute ischemic stroke has been revolutionized by the introduction of “clot busting” therapy with tissue plasminogen activator, or tPA. Unfortunately, many patients cannot benefit from this approach because they do not meet the treatment window of 3 hours, within which administration of the drug must be started or other options must be pursued. Knowing how to respond quickly and correctly to manifestations of suspected stroke is critical. In this article, Dr Meschia discusses current treatment approaches to ischemic stroke and appropriate management of complications, which can affect quality and length of life in patients who survive the initial event.